|
1）Miyake T, Kung CK, Goldwasser E. Purification of human erythropoietin. J Biol Chem. 1977; 252(15): 5558-64
|
|
|
|
2）Jacobs K, Shoemaker C, Rudersdorf R, et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature. 1985; 313(6005): 806-10
|
|
|
|
|
|
3）Lin FK, Suggs S, Lin CH, et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A. 1985; 82(22): 7580-4
|
|
|
|
|
4）Winearls CG, Oliver DO, Pippard MJ, et al. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986; 2(8517): 1175-8
|
|
|
|
|
|
5）Semenza GL, Nejfelt MK, Chi SM, et al. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci U S A. 1991; 88(13): 5680-4
|
|
|
|
|
|
6）Obara N, Suzuki N, Kim K, et al. Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. Blood. 2008; 111(10): 5223-32
|
|
|
|
|
|
7）Pan X, Suzuki N, Hirano I, et al. Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice. PLoS One. 2011; 6(10): e25839
|
|
|
|
|
|
8）Suzuki N, Obara N, Pan X, et al. Specific contribution of the erythropoietin gene 3' enhancer to hepatic erythropoiesis after late embryonic stages. Mol Cell Biol. 2011; 31(18): 3896-905
|
|
|
|
|
|
9）Frede S, Freitag P, Geuting L, et al. Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC. Blood. 2011; 117(18): 4905-14
|
|
|
|
|
|
10）Suzuki N, Obara N, Yamamoto M. Use of gene-manipulated mice in the study of erythropoietin gene expression. Methods Enzymol. 2007; 435: 157-77
|
|
|
|
|
|
11）Maxwell PH, Osmond MK, Pugh CW, et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int. 1993; 44(5): 1149-62
|
|
|
|
|
|
12）Asada N, Takase M, Nakamura J, et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest. 2011; 121(10): 3981-90
|
|
|
|
|
|
13）Haase VH. Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol. 2010; 299(1): F1-13
|
|
|
|
|
|
14）Eckardt KU, Koury ST, Tan CC, et al. Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney Int. 1993; 43(4): 815-23
|
|
|
|
|
|
15）Koury ST, Koury MJ, Bondurant MC, et al. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood. 1989; 74(2): 645-51
|
|
|
|
|
|
16）Pagel H, Jelkmann W, Weiss C. Erythropoietin production in the isolated perfused kidney. Biomed Biochim Acta. 1990; 49(2-3): S271-4
|
|
|
|
|
|
17）Shoemaker CB, Mitsock LD. Murine erythropoietin gene: cloning, expression, and human gene homology. Mol Cell Biol. 1986; 6(3): 849-58
|
|
|
|
|
|
18）Semenza GL, Koury ST, Nejfelt MK, et al. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci U S A. 1991; 88(19): 8725-9
|
|
|
|
|
|
19）Kochling J, Curtin PT, Madan A. Regulation of human erythropoietin gene induction by upstream flanking sequences in transgenic mice. Br J Haematol. 1998; 103(4): 960-8
|
|
|
|
|
|
20）Madan A, Lin C, Hatch SL, et al. Regulated basal, inducible, and tissue-specific human erythropoietin gene-expression in transgenic mice requires multiple cis DNA-sequences. Blood. 1995; 85(10): 2735-41
|
|
|
|
|
|
21）Makita T, Hernandez-Hoyos G, Chen TH, et al. A developmental transition in definitive erythropoiesis: erythropoietin expression is sequentially regulated by retinoic acid receptors and HNF4. Genes Dev. 2001; 15(7): 889-901
|
|
|
|
|
|
22）Galson DL, Tsuchiya T, Tendler DS, et al. The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1. Mol Cell Biol. 1995; 15(4): 2135-44
|
|
|
|
|
|
23）Makino Y, Cao R, Svensson K, et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature. 2001; 414(6863): 550-4
|
|
|
|
|
|
24）Tian YM, Yeoh KK, Lee MK, et al. Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. J Biol Chem. 2011; 286(15): 13041-51
|
|
|
|
|
|
25）Masson N, Singleton RS, Sekirnik R, et al. The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity. EMBO Rep. 2012; 13(3): 251-7
|
|
|
|
|
|
26）Zhang N, Fu Z, Linke S, et al. The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism. Cell Metab. 2010; 11(5): 364-78
|
|
|
|
|
|
27）Maxwell PH, Ferguson DJ, Nicholls LG, et al. The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int. 1997; 52(3): 715-24
|
|
|
|
|
|
28）Chandra M, Clemons GK, McVicar MI. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure. J Pediatr. 1988; 113(6): 1015-21
|
|
|
|
|
|
29）Tan CC, Tan LH, Eckardt KU. Erythropoietin production in rats with post-ischemic acute renal failure. Kidney Int. 1996; 50(6): 1958-64
|
|
|
|
|
|
30）Tong Z, Yang Z, Patel S, et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A. 2008; 105(19): 6998-7003
|
|
|
|
|
|
31）Weidemann A, Kerdiles YM, Knaup KX, et al. The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. J Clin Invest. 2009; 119(11): 3373-83
|
|
|
|
|
|
32）Miro-Murillo M, Elorza A, Soro-Arnaiz I, et al. Acute Vhl gene inactivation induces cardiac HIF-dependent erythropoietin gene expression. PLoS One. 2011; 6(7): e22589
|
|
|
|
|
|
33）Rankin EB, Wu C, Khatri R, et al. The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell. 2012; 149(1): 63-74
|
|
|
|
|
|
34）Weidemann A, Krohne TU, Aguilar E, et al. Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia. 2010; 58(10): 1177-85
|
|
|
|
|
|
35）Scheerer N, Dunker N, Imagawa S, et al. The anemia of the newborn induces erythtopoietin expression in the developing mouse retina. Am J Physiol Regul Integr Comp Physiol. 2010; 299(1): R111-8
|
|
|
|
|
|
36）Lange CA, Luhmann UF, Mowat FM, et al. Von Hippel-Lindau protein in the RPE is essential for normal ocular growth and vascular development. Development. 2012; 139(13): 2340-50
|
|
|
|
|
|
37）Yoon D, Pastore YD, Divoky V, et al. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem. 2006; 281(35): 25703-11
|
|
|
|
|
|
38）Gruber M, Hu CJ, Johnson RS, et al. Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A. 2007; 104(7): 2301-6
|
|
|
|
|
|
39）Kapitsinou PP, Liu Q, Unger TL, et al. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood. 2010; 116(16): 3039-48
|
|
|
|
|
|
40）Rankin EB, Biju MP, Liu Q, et al. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest. 2007; 117(4): 1068-77
|
|
|
|
|
|
41）Takeda K, Aguila HL, Parikh NS, et al. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood. 2008; 111(6): 3229-35
|
|
|
|
|
|
42）Minamishima YA, Kaelin WG, Jr. Reactivation of hepatic EPO synthesis in mice after PHD loss. Science. 2010; 329(5990): 407
|
|
|
|
|
|
43）Rankin EB, Higgins DF, Walisser JA, et al. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol Cell Biol. 2005; 25(8): 3163-72
|
|
|
|
|